Cita APA

You, Y., Xu, Z., & Chen, Y. (2018). Doxorubicin conjugated with a trastuzumab epitope and an MMP-2 sensitive peptide linker for the treatment of HER2-positive breast cancer. Drug Deliv.

Citación estilo Chicago

You, Yiwen, Zhiyuan Xu, y Yun Chen. "Doxorubicin Conjugated With a Trastuzumab Epitope and an MMP-2 Sensitive Peptide Linker for the Treatment of HER2-positive Breast Cancer." Drug Deliv 2018.

Cita MLA

You, Yiwen, Zhiyuan Xu, y Yun Chen. "Doxorubicin Conjugated With a Trastuzumab Epitope and an MMP-2 Sensitive Peptide Linker for the Treatment of HER2-positive Breast Cancer." Drug Deliv 2018.

Precaución: Estas citas no son 100% exactas.